Literature DB >> 30846078

A 35-Year-Old Woman With Shock, Pulseless Electrical Activity Arrest, and Hemodynamic Collapse.

Jonathan W Schuenemeyer1, Leslie A Jette-Kelly2.   

Abstract

CASE
PRESENTATION: A 35-year-old woman presented with 2 days of nausea, abdominal pain, and fatigue. On the day of presentation, her abdominal pain worsened, she developed progressive somnolence, and had several bouts of nonbloody, nonbilious emesis. She denied prior headache, rashes, and toxic or illicit ingestions. The patient had a medical history of diabetes mellitus type 2, hyperlipidemia, and mild cognitive delay (highly functional, maintaining a job, home, and medication responsibilities). She reported taking only simvastatin and short-acting insulin. She had an unknown adverse reaction to metformin. She was a nonsmoker and denied history of drug and alcohol use.
Copyright © 2018 American College of Chest Physicians. Published by Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2019        PMID: 30846078      PMCID: PMC6435893          DOI: 10.1016/j.chest.2018.08.1030

Source DB:  PubMed          Journal:  Chest        ISSN: 0012-3692            Impact factor:   9.410


  10 in total

Review 1.  Metformin-associated lactic acidosis requiring hospitalization. A national 10 year survey and a systematic literature review.

Authors:  F Renda; P Mura; G Finco; F Ferrazin; L Pani; G Landoni
Journal:  Eur Rev Med Pharmacol Sci       Date:  2013-02       Impact factor: 3.507

Review 2.  Metformin in patients with type 2 diabetes and kidney disease: a systematic review.

Authors:  Silvio E Inzucchi; Kasia J Lipska; Helen Mayo; Clifford J Bailey; Darren K McGuire
Journal:  JAMA       Date:  2014 Dec 24-31       Impact factor: 56.272

Review 3.  Lactic acidosis induced by metformin: incidence, management and prevention.

Authors:  Jean-Daniel Lalau
Journal:  Drug Saf       Date:  2010-09-01       Impact factor: 5.606

4.  Oxygen consumption is depressed in patients with lactic acidosis due to biguanide intoxication.

Authors:  Alessandro Protti; Riccarda Russo; Paola Tagliabue; Sarah Vecchio; Mervyn Singer; Alain Rudiger; Giuseppe Foti; Anna Rossi; Giovanni Mistraletti; Luciano Gattinoni
Journal:  Crit Care       Date:  2010-02-19       Impact factor: 9.097

Review 5.  Risk of fatal and nonfatal lactic acidosis with metformin use in type 2 diabetes mellitus.

Authors:  Shelley R Salpeter; Elizabeth Greyber; Gary A Pasternak; Edwin E Salpeter Posthumous
Journal:  Cochrane Database Syst Rev       Date:  2010-01-20

Review 6.  Metformin-associated lactic acidosis: Current perspectives on causes and risk.

Authors:  Ralph DeFronzo; G Alexander Fleming; Kim Chen; Thomas A Bicsak
Journal:  Metabolism       Date:  2015-10-09       Impact factor: 8.694

7.  Metformin-associated lactic acidosis: a prognostic and therapeutic study.

Authors:  Alexandre Seidowsky; Saad Nseir; Nicole Houdret; François Fourrier
Journal:  Crit Care Med       Date:  2009-07       Impact factor: 7.598

8.  Management of metformin-associated lactic acidosis by continuous renal replacement therapy.

Authors:  Geoffray Keller; Martin Cour; Romain Hernu; Julien Illinger; Dominique Robert; Laurent Argaud
Journal:  PLoS One       Date:  2011-08-11       Impact factor: 3.240

9.  Outcome of severe lactic acidosis associated with metformin accumulation.

Authors:  Sigrun Friesecke; Peter Abel; Markus Roser; Stephan B Felix; Soeren Runge
Journal:  Crit Care       Date:  2010-12-20       Impact factor: 9.097

Review 10.  Serum lactate level and mortality in metformin-associated lactic acidosis requiring renal replacement therapy: a systematic review of case reports and case series.

Authors:  Hung-Chieh Yeh; I-Wen Ting; Ching-Wei Tsai; Jenn-Yu Wu; Chin-Chi Kuo
Journal:  BMC Nephrol       Date:  2017-07-10       Impact factor: 2.388

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.